Efficacy and Safety of Ultrasound-guided Mammotome Minimally Invasive Potary Surgery in the Treatment of Benign Breast Nodules
Objective:To explore the efficacy and safety of ultrasound-guided Mammotome minimally invasive potary surgery in the treatment of patients with benign breast nodules.Method:A total of 80 patients with benign breast nodules treated in the People's Hospital of Ruichang from March 2020 to December 2022 were selected and divided into study group(n=40)and control group(n=40)according to random number table method.The control group was given conventional open resection and the study group was given ultrasound-guided Mammotome minimally invasive potary surgery.The clinical indexes,scar morphology,breast appearance aesthetics and incidence of complications were compared between the two groups.Result:Compared with the control group,the operation time of the study group was shorter,the intraoperative bleeding volume of the study group was less,and the visual analogue scale(VAS)score 1 day after operation was lower,the differences were statistically significant(P<0.05).The Vancouver scar scale(VSS)scores of the study group were lower than those of the control group at 3 months after operation,the differences were statistically significant(P<0.05).The excellent and good rate of breast appearance aesthetics in the study group(100%)was higher than that in the control group(85.00%),the difference was statistically significant(P<0.05).The complication rate of the study group(5.00%)was lower than that of the control group(22.50%),the difference was statistically significant(P<0.05).Conclusion:Ultrasound-guided Mammotome minimally invasive potary surgery in the treatment of benign breast nodules can reduce postoperative pain,reduce the impact on breast appearance aesthetics,and reduce the incidence of complications.
Benign breast nodulesUltrasound-guidedMammotome minimally invasive potary surgeryEfficacySafety
万方数据
维普
